These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 15911426

  • 21. Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types.
    Schmitz M, Scheungraber C, Herrmann J, Teller K, Gajda M, Runnebaum IB, Dürst M.
    J Clin Virol; 2009 Apr; 44(4):302-7. PubMed ID: 19223232
    [Abstract] [Full Text] [Related]

  • 22. PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets.
    Remmerbach TW, Brinckmann UG, Hemprich A, Chekol M, Kühndel K, Liebert UG.
    J Clin Virol; 2004 Aug; 30(4):302-8. PubMed ID: 15163418
    [Abstract] [Full Text] [Related]

  • 23. Establishment of an efficient multiplex real-time PCR assay for human papillomavirus genotyping in cervical cytology specimens: comparison with hybrid capture II.
    Lee JH, Lee NW, Hong SW, Nam YS, Choi JW, Kim YS.
    Cytopathology; 2011 Aug; 22(4):261-8. PubMed ID: 20636403
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Prevalence of HPV genotypes determined by PCR and DNA sequencing in cervical specimens from French women with or without abnormalities.
    Pannier-Stockman C, Segard C, Bennamar S, Gondry J, Boulanger JC, Sevestre H, Castelain S, Duverlie G.
    J Clin Virol; 2008 Aug; 42(4):353-60. PubMed ID: 18485810
    [Abstract] [Full Text] [Related]

  • 26. [Genotyping of human papillomavirus genotyes in cervical scrapes by line probe assay].
    Wang J, Bakkers J, Melchers WJ.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Mar; 13(1):9-12. PubMed ID: 12759942
    [Abstract] [Full Text] [Related]

  • 27. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
    Zheng Y, Peng ZL, Lou JY, Wang H.
    Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The evaluation of human papillomavirus genotyping in cervical liquid-based cytology specimens; using the Roche Linear Array HPV genotyping assay.
    Jamison J, Wilson RT, Carson J.
    Cytopathology; 2009 Aug; 20(4):242-8. PubMed ID: 19291176
    [Abstract] [Full Text] [Related]

  • 30. HPV DNA detection and typing in cervical scrapes.
    Snijders PJ, van den Brule AJ, Jacobs MV, Pol RP, Meijer CJ.
    Methods Mol Med; 2005 Aug; 119():101-14. PubMed ID: 16350400
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Simultaneous detection by consensus multiplex PCR of high- and low-risk and other types of human papilloma virus in clinical samples.
    Zheng PS, Li SR, Iwasaka T, Song J, Cui MH, Sugimori H.
    Gynecol Oncol; 1995 Aug; 58(2):179-83. PubMed ID: 7622102
    [Abstract] [Full Text] [Related]

  • 35. High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women.
    Prétet JL, Dalstein V, Monnier-Benoit S, Delpeut S, Mougin C.
    J Clin Virol; 2004 Oct; 31(2):140-7. PubMed ID: 15364271
    [Abstract] [Full Text] [Related]

  • 36. Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA.
    Perrons C, Jelley R, Kleter B, Quint W, Brink N.
    J Clin Virol; 2005 Apr; 32(4):278-85. PubMed ID: 15780805
    [Abstract] [Full Text] [Related]

  • 37. Comparison of the PapilloCheck DNA micro-array Human Papillomavirus detection assay with Hybrid Capture II and PCR-enzyme immunoassay using the GP5/6+ primer set.
    Jones J, Powell NG, Tristram A, Fiander AN, Hibbitts S.
    J Clin Virol; 2009 Jun; 45(2):100-4. PubMed ID: 19394266
    [Abstract] [Full Text] [Related]

  • 38. The spectrum of cervical diseases induced by low-risk and undefined-risk HPVS: implications for patient management.
    Várnai AD, Bollmann M, Bánkfalvi A, Griefingholt H, Pfening N, Schmitt C, Pajor L, Bollmann R.
    Anticancer Res; 2007 Jun; 27(1B):563-70. PubMed ID: 17348442
    [Abstract] [Full Text] [Related]

  • 39. Universal ProbeLibrary based real-time PCR assay for detection and confirmation of human papillomavirus genotype 52 infections.
    Kocjan BJ, Poljak M, Seme K.
    J Virol Methods; 2010 Feb; 163(2):492-4. PubMed ID: 19883693
    [Abstract] [Full Text] [Related]

  • 40. Detection and typing of 46 genital human papillomaviruses by the L1F/L1R primer system based multiplex PCR and hybridization.
    Jeney C, Takács T, Sebe A, Schaff Z.
    J Virol Methods; 2007 Mar; 140(1-2):32-42. PubMed ID: 17169438
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.